Let’s work together –
Pharmaceutical
out-licensing with Olpha

Olpha has a long-term strategy to expand our product portfolio and develop sustainable business in different territories. It is a continuous process — new products are constantly being evaluated and included in the portfolio.

Contact us

For successful partnership we ensure reliable communication and high-level support. To expand your product line or enter new markets, Olpha will find the best option to achieve your goals. Our partners already cover key regions, including the EU, CIS, Southeast Asia, Africa and the Middle East.

Build your pharmaceutical
product portfolio with Olpha

Key areas of final dosage forms to add to your product offering and grow your business efficiently.

Discover other therapeutic areas

Anti-diabetes treatment

Rivaroxaban
Dapagliflozin + Metformin
Linagliptin
Dapagliflozin
Empagliflozin

Oncology

Enzalutamide
Palbociclib
Ibrutinib
Cabozantinib
Olaparib

Cardiology

Rivaroxaban
Sacubitril+Valsartan

Production achievements

The highlights of our production achievements

24/7

production

> 1 bn

production capacity for
tablets and capsules per year

8.1m €

investment in
R&D in 2022

22m €

investment in new generic medicine portfolio in 2024

Why work with Olpha?

Expertise and
experience

With a team of 800+ professional employees and 50+ years of experience, Olpha is an expert in the development and production of finished dosage forms and active pharmaceutical ingredients and intermediates in a vast range of therapeutic areas.

Production plant
and equipment

Our production plant is located in the European Union, in Latvia, and has a 480,000 square meter area with easy access to the highway and airport. Our laboratories are equipped with modern, industry standard instruments.

Individual approach

We approach each client’s needs and evaluate each cooperation on an individual level. We believe the best way of collaborating is finding the most suitable solution for any need together.

Our priority – a reliable process and high quality production

Olpha is develops generics as well as APIs and
stands out with the full-cycle production offering.

Reliable supply chains

Olpha ensures consistent product availability to meet
the market demand.

Cost efficiency

Efficient production processes, lower labour costs and regionally
developed logistics result in greater cost efficiency.

Highest quality standards

Olpha holds its production to the highest industry quality standards.
See more information on quality control and assurance on our
Product governance page.

Sustainability

Our processes include effective sustainability measures, ensuring
that our business processes are good for people and the planet.
See more information on our Sustainability section.

Let’s work together to bring better health closer to people

For Co-Development and Contract Manufacturing

Business Development Department

bdd@olpha.eu

Cooperate with Olpha

Media

For media relations and partnerships

Business

For distributors and business partners

Social Initiatives

For social causes and potential projects

Careers

For open positions and career opportunties

Attention!

Information on prescription medications should only be viewed by healthcare professionals.

Are you a health care worker?